Literature DB >> 23548866

Ex vivo expansion of canine cytotoxic large granular lymphocytes exhibiting characteristics of natural killer cells.

Dong-Jun Shin1, Ji-Yun Park, Youn-Young Jang, Je-Jung Lee, Youn-Kyung Lee, Myung-Geun Shin, Ji-Youn Jung, William E Carson, Duck Cho, Sang-Ki Kim.   

Abstract

Canine NK cells still are not well-characterized due to the lack of information concerning specific NK cell markers and the fact that NK cells are not an abundant cell population. In this study, we selectively expanded the canine cytotoxic large granular lymphocytes (CLGLs) that exhibit morphologic, genetic, and functional characteristics of NK cells from normal donor PBMCs. The cultured CLGLs were characterized by a high proportion of CD5(dim) expressing cells, of which the majority of cells co-expressed CD3 and CD8, but did not express TCRαβ and TCRγδ. The phenotype of the majority of the CLGLs was CD5(dim)CD3(+)CD8(+) TCRαβ(-)TCRγδ(-)CD4(-)CD21(-)CD11c(+/-)CD11d(+/-)CD44(+). The expression of mRNAs for NK cell-associated receptors (NKG2D, NKp30, NKp44, Ly49, perforin, and granzyme B) were highly upregulated in cultured CLGLs. Specifically, NKp46 was remarkably upregulated in the cultured CLGLs compared to PBMCs. The mRNAs for the NKT-associated iTCRα gene in CLGLs was present at a basal level. The cytotoxic activity of the CLGLs against canine NK cell-sensitive CTAC cells was remarkably elevated in a dose-dependent manner, and the CLGLs produced large amounts of IFN-γ. The antitumor activity of CLGLs extended to different types of canine tumor cells (CF41.Mg and K9TCC-pu-AXC) without specific antigen recognition. These results are consistent with prior reports, and strongly suggest that the selectively expanded CLGLs represent a population of canine NK cells. The results of this study will contribute to future research on canine NK cells as well as NK cell-based immunotherapy.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23548866      PMCID: PMC3769186          DOI: 10.1016/j.vetimm.2013.03.006

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  40 in total

1.  Ex vivo expansion of canine dendritic cells from CD34+ bone marrow progenitor cells.

Authors:  H G Hägglund; P A McSweeney; G Mathioudakis; B Bruno; G E Georges; M J Gass; P Moore; G E Sale; R Storb; R A Nash
Journal:  Transplantation       Date:  2000-11-27       Impact factor: 4.939

Review 2.  Spontaneously occurring tumors of companion animals as models for human cancer.

Authors:  D M Vail; E G MacEwen
Journal:  Cancer Invest       Date:  2000       Impact factor: 2.176

Review 3.  Innate or adaptive immunity? The example of natural killer cells.

Authors:  Eric Vivier; David H Raulet; Alessandro Moretta; Michael A Caligiuri; Laurence Zitvogel; Lewis L Lanier; Wayne M Yokoyama; Sophie Ugolini
Journal:  Science       Date:  2011-01-07       Impact factor: 47.728

4.  Influence of different tumour types on natural cytotoxicity (NK cell activity) and mitogen-induced lymphocyte proliferation in isolated blood lymphocytes from 110 dogs with tumours.

Authors:  J Funk; G Schmitz; U Bach; K Failing; E Burkhardt
Journal:  Res Vet Sci       Date:  2003-04       Impact factor: 2.534

5.  Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.

Authors:  Loredana Ruggeri; Marusca Capanni; Elena Urbani; Katia Perruccio; Warren D Shlomchik; Antonella Tosti; Sabrina Posati; Daniela Rogaia; Francesco Frassoni; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

Review 6.  Divergent and convergent evolution of NK-cell receptors.

Authors:  R Barten; M Torkar; A Haude; J Trowsdale; M J Wilson
Journal:  Trends Immunol       Date:  2001-01       Impact factor: 16.687

7.  A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells.

Authors:  S Carlens; M Gilljam; B J Chambers; J Aschan; H Guven; H G Ljunggren; B Christensson; M S Dilber
Journal:  Hum Immunol       Date:  2001-10       Impact factor: 2.850

Review 8.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

Authors:  A Moretta; C Bottino; M Vitale; D Pende; C Cantoni; M C Mingari; R Biassoni; L Moretta
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

9.  Serologic evidence of pandemic (H1N1) 2009 infection in dogs, Italy.

Authors:  William G Dundon; Paola De Benedictis; Elisabetta Viale; Ilaria Capua
Journal:  Emerg Infect Dis       Date:  2010-12       Impact factor: 6.883

10.  Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process.

Authors:  Jan Spanholtz; Frank Preijers; Marleen Tordoir; Carel Trilsbeek; Jos Paardekooper; Theo de Witte; Nicolaas Schaap; Harry Dolstra
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

View more
  15 in total

1.  NCR1+ cells in dogs show phenotypic characteristics of natural killer cells.

Authors:  Christine Grøndahl-Rosado; Tina B Bønsdorff; Hege C Brun-Hansen; Anne K Storset
Journal:  Vet Res Commun       Date:  2014-12-02       Impact factor: 2.459

2.  Activating natural killer (NK) cytotoxicity of canine CD5-CD21- cells requires low surface CD5 density NK cells.

Authors:  C S Lin; C P Chang; H C Chiang; T F Chuang; C H Hsu; C C Liu
Journal:  Iran J Vet Res       Date:  2018       Impact factor: 1.376

Review 3.  Canine cancer immunotherapy studies: linking mouse and human.

Authors:  Jiwon S Park; Sita S Withers; Jaime F Modiano; Michael S Kent; Mingyi Chen; Jesus I Luna; William T N Culp; Ellen E Sparger; Robert B Rebhun; Arta M Monjazeb; William J Murphy; Robert J Canter
Journal:  J Immunother Cancer       Date:  2016-12-20       Impact factor: 13.751

4.  Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial.

Authors:  Robert J Canter; Steven K Grossenbacher; Jennifer A Foltz; Ian R Sturgill; Jiwon S Park; Jesus I Luna; Michael S Kent; William T N Culp; Mingyi Chen; Jaime F Modiano; Arta M Monjazeb; Dean A Lee; William J Murphy
Journal:  J Immunother Cancer       Date:  2017-12-19       Impact factor: 13.751

5.  Antigen-Specific CD4+CD8+ Double-Positive T Cells Are Increased in the Blood and Spleen During Ehrlichia chaffeensis Infection in the Canine Host.

Authors:  Jodi L McGill; Ying Wang; Chanran K Ganta; Gunavanthi D Y Boorgula; Roman R Ganta
Journal:  Front Immunol       Date:  2018-07-11       Impact factor: 7.561

6.  Canine non-B, non-T NK lymphocytes have a potential antibody-dependent cellular cytotoxicity function against antibody-coated tumor cells.

Authors:  Yoseop Kim; Soo-Hyeon Lee; Cheol-Jung Kim; Je-Jung Lee; Dohyeon Yu; Soomin Ahn; Dong-Jun Shin; Sang-Ki Kim
Journal:  BMC Vet Res       Date:  2019-10-14       Impact factor: 2.741

7.  Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer.

Authors:  Sean J Judge; Mio Yanagisawa; Ian R Sturgill; Sarah B Bateni; Alicia A Gingrich; Jennifer A Foltz; Dean A Lee; Jaime F Modiano; Arta M Monjazeb; William T N Culp; Robert B Rebhun; William J Murphy; Michael S Kent; Robert J Canter
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

Review 8.  There and back again: Translating adoptive cell therapy to canine cancer and improving human treatment.

Authors:  Samuel A Brill; Douglas H Thamm
Journal:  Vet Comp Oncol       Date:  2021-07-18       Impact factor: 2.385

9.  NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells.

Authors:  Jennifer A Foltz; Srinivas S Somanchi; Yanwen Yang; Arianexys Aquino-Lopez; Erin E Bishop; Dean A Lee
Journal:  Front Immunol       Date:  2016-11-23       Impact factor: 7.561

10.  Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3+CD5dimCD21- Cytotoxic Large Granular Lymphocytes.

Authors:  Soo-Hyeon Lee; Dong-Jun Shin; Yoseop Kim; Cheol-Jung Kim; Je-Jung Lee; Mee Sun Yoon; Tung Nguyen Thanh Uong; Dohyeon Yu; Ji-Youn Jung; Duck Cho; Bock-Gie Jung; Sang-Ki Kim; Guk-Hyun Suh
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.